- Home
- MSGS vs ALKS Comparison
MSGS vs ALKS Comparison
Compare MSGS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSGS | ALKS |
|---|---|---|
| Founded | 1879 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 8.7B |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MSGS | ALKS |
|---|---|---|
| Price | $416.35 | $43.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 20 |
| Target Price | ★ $480.67 | $56.21 |
| AVG Volume (30 Days) | 321.3K | ★ 2.1M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.41 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | ★ $1,475,899,000.00 |
| Revenue This Year | N/A | $23.54 |
| Revenue Next Year | $3.79 | $6.53 |
| P/E Ratio | $1,291.53 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $207.90 | $27.00 |
| 52 Week High | $438.93 | $55.67 |
Technical Indicators
Market Signals| Indicator | MSGS | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 60.23 | 56.43 |
| Support Level | $379.80 | $39.41 |
| Resistance Level | $420.06 | $47.40 |
| Average True Range (ATR) | 10.90 | 1.36 |
| MACD | 0.71 | 0.63 |
| Stochastic Oscillator | 93.23 | 78.54 |
Price Performance
Historical ComparisonAbout MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp is owns and operates a portfolio of assets featuring some of the recognized teams in all of sports, including the Knicks of the National Basketball Association (NBA) and the Rangers of the National Hockey League (NHL). The company has one operating and reportable segment.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.